v3.26.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Revenue Recognition) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Product Information [Line Items]        
Total Revenue $ 485,385 $ 118,146 $ 661,660 $ 189,910
Sales Of Supplements [Member]        
Product Information [Line Items]        
Total Revenue 0 1,091 $ 0 $ 2,155
Sales Of Supplements [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]        
Product Information [Line Items]        
Percentage of revenue     0.00% 1.10%
Medical Procedures [Member]        
Product Information [Line Items]        
Total Revenue 329,820 26,000 $ 434,670 $ 96,700
Medical Procedures [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]        
Product Information [Line Items]        
Percentage of revenue     65.70% 50.90%
Sales Of Biologics [Member]        
Product Information [Line Items]        
Total Revenue 151,750 87,500 $ 221,525 $ 87,500
Sales Of Biologics [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]        
Product Information [Line Items]        
Percentage of revenue     33.50% 46.10%
Services [Member]        
Product Information [Line Items]        
Total Revenue 0 2,267 $ 0 $ 2,267
Services [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]        
Product Information [Line Items]        
Percentage of revenue     0.00% 1.20%
Shipping And Delivery [Member]        
Product Information [Line Items]        
Total Revenue $ 3,815 $ 1,288 $ 5,465 $ 1,288
Shipping And Delivery [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]        
Product Information [Line Items]        
Percentage of revenue     0.80% 0.70%
Total Revenue [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]        
Product Information [Line Items]        
Percentage of revenue     100.00% 100.00%